OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
24 hedge funds and large institutions have $6.29M invested in Ocera Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$164K | |
| 2 | +$147K | |
| 3 | +$116K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$95K |
| 5 |
AWS
AJ Wealth Strategies
New York
|
+$60K |
Top Sellers
| 1 | -$381K | |
| 2 | -$129K | |
| 3 | -$73K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$39.3K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$36.7K |